Journal profile · Multiple
Drug and Alcohol Dependence Reports
ISSN 2772-7246 · Elsevier · Netherlands
Drug and Alcohol Dependence Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.5 (journal website); fully open access; APC about USD 2,230; median 84 days to acceptance (101 articles, last 24 months); 88 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Drug and Alcohol Dependence Reports is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Substance Abuse Treatment and Outcomes, Opioid Use Disorder Treatment and HIV, Drug Use, Sexual Risk, together about 55.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Drug and Alcohol Dependence Reports is an Open Access companion journal to Drug and Alcohol Dependence, which offers an alternative home for high quality, methodologically sound addiction science.DAD Reports is a journal dedicated to the dissemination of original research, scholarly reviews, commentaries, and policy analyses in the field of drug, alcohol and tobacco use, misuse and dependence. The journal maintains the expansive coverage of all areas of research related to the study of drug dependence as is published in its parent journal. These include studies of the cellular and molecular actions, chemistry, pharmacology, neuroscience, epidemiology, sociology, economics, and behavioral manifestations of psychoactive substances, inclusive of studies on intervention and prevention. This broad coverage of the addictions' field provides researchers with an in-depth over encompassing knowledge base that can help inform individual research paths with the goal of improving science. Facilitating momentum in moving addiction science from the laboratory to the clinic is an important aim of its editorial team.While relevance to addiction science and a methodologically sound approach are prerequisite for publication, research that may be nuanced, or narrower in focus (i.e., specific populations, novel drugs) are of interest, as well as reports that may be considered preliminary, exploratory, novel or pilot. Thought-provoking or intriguing short communications and letters to the editors are evaluated.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Teresa FranklinPublisher website
Editorial board by country: 1 in mainland China (about 2%); most named United States 55, Canada 3, Australia 3, Japan 2, Mainland China 1 (65 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Substance Abuse Treatment and OutcomesMedicine22.5%
- Opioid Use Disorder TreatmentMedicine20.6%
- HIV, Drug Use, Sexual RiskMedicine12.1%
- Smoking Behavior and CessationMedicine5.1%
- Cannabis and Cannabinoid ResearchMedicine4.6%
- Prenatal Substance Exposure EffectsMedicine4.5%
- Forensic Toxicology and Drug AnalysisPharmacology, Toxicology and Pharmaceutics4.2%
- Neurotransmitter Receptor Influence on BehaviorNeuroscience3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Psychiatry | Zone 4 |
| Minor | Substance Abuse | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Substance Abuse | Zone 3 |
| Minor | Psychiatry | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.5Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- CiteScore (publisher)
- 4.9Publisher website ·
- SJR 2026-06
- 1.46LetPub ·
- SNIP 2026-06
- 1.23LetPub ·
- h-index
- 25OpenAlex ·
- i10-index
- 95OpenAlex ·
- 2-year mean citedness
- 3.46OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 84LetPub ·
Articles by year OpenAlex count · 465 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 72 | 72 | 15 |
| 2025 | 88 | 88 | 185 |
| 2024 | 99 | 99 | 695 |
| 2023 | 81 | 81 | 823 |
| 2022 | 103 | 103 | 1,502 |
| 2021 | 22 | 22 | 107 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
84 daysMedian, submission to acceptance · P25–P75 66 days – 111 days
- Acceptance to online
- median 2 days (101 articles)
- Submission to online
- median 88 days
- Sample
- 101 articles with submission and acceptance dates (190 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to first decision
- 5 daysPublisher website ·
- First decision after review
- 45 daysPublisher website ·
- Submission to acceptance
- 93 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,230 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,120 / EUR 1,980 / GBP 1,700 / JPY 262,940 | — | — | |
| LetPub | USD 2,000 | Yes | — | |
| Publisher website | USD 2,790 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
- Manuscript length
- ≤ 4,000 words
- Reference style
- Author–date
- Highlights
- Required
- Graphical abstract
- Optional
Article types accepted17, with length limits
- case report1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- commentaries and editorials6) Commentaries and editorials are only considered at the invitation of the Editors.Length not stated
- commentary1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- editorial1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- full-length reports1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- letter1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- letter to the editor1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- letters to the editor1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- original paper1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- registered report1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- registered reports5) Registered Reports (click here for more details). These submissions undergo a two-phase review process in which study rationale and methodology are considere…Length not stated
- review1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- review article1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…main text ≤ 6,000 words
- review articles2) Review Articles of specialized topics within the scope of the journal. Typically, these are systematic reviews of a field of research. A Review Article typic…Length not stated
- short communication1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
- short communications3) Short Communications reporting on research that has progressed to the stage where a preliminary publication is appropriate. The maximum length is 2000 words …Length not stated
- systematic review1) Full-length Reports reporting original results of research within the field of drug, alcohol and tobacco use and dependence. A Full-length Report typically s…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2772-7246
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Drug and Alcohol Dependence Reports
What CAS zone is Drug and Alcohol Dependence Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Drug and Alcohol Dependence Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Psychiatry / Substance Abuse. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Drug and Alcohol Dependence Reports?
The journal's website gives an impact factor of 3.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.9, h-index 25.
How long does peer review take at Drug and Alcohol Dependence Reports?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 84 days (interquartile range 66–111 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Drug and Alcohol Dependence Reports?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7; Manuscript length: ≤ 4,000 words; Reference style: Author–date; Highlights: Required; Graphical abstract: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Drug and Alcohol Dependence Reports based?
Of the 65 board members whose country the journal's board page names, 1 (about 2%) are in mainland China; the countries named most often are United States (55), Canada (3) and Australia (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Drug and Alcohol Dependence Reports?
According to LetPub and DOAJ records, Drug and Alcohol Dependence Reports is indexed in ESCI, Scopus and DOAJ.
Is Drug and Alcohol Dependence Reports open access, and what is the APC?
Drug and Alcohol Dependence Reports is a fully open-access journal. APC about USD 2,230.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .